Yoshihisa Matsukawa Selected Research

Yoshihisa Matsukawa Research Topics

Disease

19	Lower Urinary Tract Symptoms 01/2022 - 12/2009
12	Neoplasms (Cancer) 07/2022 - 08/2005
12	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 03/2008
11	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 04/2009
11	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2020 - 01/2013
11	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2019 - 09/2011
6	Urinary Incontinence 04/2021 - 01/2010
5	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2020 - 02/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 05/2019 - 08/2005
5	Stress Urinary Incontinence 01/2019 - 01/2010
4	Pain (Aches) 01/2022 - 02/2016
4	Underactive Urinary Bladder 04/2021 - 04/2008
4	Peritoneal Fibrosis 01/2018 - 03/2010
3	Neoplasm Metastasis (Metastasis) 02/2021 - 07/2008
3	Fibrosis (Cirrhosis) 01/2018 - 03/2010
2	Carcinoma (Carcinomatosis) 07/2022 - 04/2009
2	Pelvic Pain 01/2022 - 01/2020
2	Prostatitis 01/2022 - 01/2020
2	Seminoma 01/2018 - 07/2008
2	Peritonitis 01/2016 - 10/2013
2	Hyperplasia 09/2011 - 04/2011
2	Ischemia 11/2010 - 05/2005
2	Hemorrhage 04/2009 - 08/2005
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Adenocarcinoma 02/2021
1	Hypertrophy 08/2020
1	Disease Progression 11/2019
1	Solitary Kidney 05/2019
1	Sarcopenia 01/2019
1	Cerebral Hemorrhage 01/2019
1	Margins of Excision 01/2019
1	Rhabdomyosarcoma 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Inguinal Hernia (Direct Inguinal Hernia) 06/2018
1	Colitis 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	Teratoma (Teratoid Tumor) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Hypoxia (Hypoxemia) 01/2017

Drug/Important Bio-Agent (IBA)

12	silodosin FDA Link 04/2021 - 12/2009
5	Tadalafil (Cialis)FDA Link 04/2021 - 01/2018
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 02/2016
5	naftopidilIBA 01/2019 - 04/2011
4	mirabegronIBA 08/2020 - 04/2015
3	Testosterone (Sustanon)FDA Link 01/2022 - 02/2016
3	Therapeutic UsesIBA 12/2020 - 09/2017
3	Dutasteride (Avodart)FDA Link 10/2017 - 08/2014
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2013 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2017
2	Docetaxel (Taxotere)FDA Link 02/2021 - 06/2018
2	fesoterodine FDA Link 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 01/2018
2	Dialysis SolutionsIBA 01/2018 - 03/2010
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2010
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2009 - 05/2005
1	pembrolizumabIBA 07/2022
1	GP 4 (GP4)IBA 04/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Hormones (Hormone)IBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	indolepropanol phosphate (IPP)IBA 01/2020
1	AndrogensIBA 01/2020
1	Androgen Antagonists (Antiandrogens)IBA 11/2019
1	Flutamide (Eulexin)FDA LinkGeneric 11/2019
1	bicalutamide (Casodex)FDA LinkGeneric 11/2019
1	Sunitinib (Sutent)FDA Link 05/2019
1	AlbuminsIBA 01/2019
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	resiniferatoxinIBA 01/2018
1	CatecholaminesIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Sulfonic AcidsIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	8-Hydroxy-2'-DeoxyguanosineIBA 05/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017

Therapy/Procedure

14	Therapeutics 02/2022 - 03/2010
14	Prostatectomy (Retropubic Prostatectomy) 04/2021 - 04/2008
5	Nephrectomy 01/2018 - 08/2005
4	Castration 12/2020 - 06/2018
4	Peritoneal Dialysis 01/2018 - 03/2010
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2014 - 01/2010
2	Aftercare (After-Treatment) 01/2019 - 01/2018
2	Radiotherapy 01/2018 - 01/2018
1	Metastasectomy 02/2022
1	Massage (Zone Therapy) 01/2022
1	Urinary Catheters 04/2021
1	Pelvic Exenteration 02/2021
1	Solid-State Lasers 01/2019